Palzen 0.25 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Palzen 0.25 mg Injection contains palonosetron, an antiemetic medicine. Its labelling describes it for controlling vomiting and nausea due to conditions such as an upset stomach, and for relieving nausea or vomiting due to surgery, cancer drug therapy, or radiotherapy. It is described as not reducing other side effects of cancer treatment. The doctor decides the correct dose, whether it is used alone or with other medicines, and the frequency of use.

Active ingredient
Palonosetron
Strength
0.25 mg
Dosage form
Solution for injection
Therapeutic class
Antiemetic (5-HT3 receptor antagonist)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with palonosetron and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for preventing nausea and vomiting due to chemotherapy and radiotherapy
  • Described for controlling postoperative nausea and vomiting
  • Described as controlling vomiting and nausea due to conditions such as an upset stomach
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Recommended by a healthcare professional only after checking the patient’s symptoms
  • No dose should be missed during the course
  • The injection should not be self-administered; it should be given by the doctor
  • Administered under strict doctor’s supervision

Described Side Effects

The medicine is described as not having serious side effects. Those that may be noticed include:

  • Pain at the site where the injection is applied
  • Headache
  • Diarrhoea
  • Constipation
  • Dizziness or drowsiness

Symptoms are described as disappearing once the medicine is stopped. A healthcare professional should be consulted if they persist for long.

Precautions

  • Smoking and alcohol should be avoided while taking the medicine
  • The doctor should be told, especially about epilepsy, heart, cancer, or depression-related medicines
  • Conditions such as liver problems or a blockage in the stomach should be disclosed to the doctor
  • Pregnant or breastfeeding women should speak to a healthcare professional before taking the injection

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains palonosetron and is used to prevent nausea and vomiting due to chemotherapy and radiotherapy and to control postoperative nausea and vomiting. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given by the doctor under strict supervision after checking symptoms, and it should not be self-administered.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services